Facing Stronger Global Competition And A Patent Cliff, Eisai Explores New Business Model
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Faced with strengthening global competition involving rival drugs and the approaching expiration of a patent on a blockbuster product, Japan's Eisai is overhauling its decade-old business model